These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24738485)

  • 41. Immunization with HBsAg-Fc fusion protein induces a predominant production of Th1 cytokines and reduces HBsAg level in transgenic mice.
    Meng ZF; Wang HJ; Yao X; Wang XY; Wen YM; Dai JX; Xie YH; Xu JQ
    Chin Med J (Engl); 2012 Sep; 125(18):3266-72. PubMed ID: 22964321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.
    Jesus S; Soares E; Borchard G; Borges O
    Nanomedicine (Lond); 2017 Oct; 12(19):2335-2348. PubMed ID: 28868964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
    Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
    J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
    Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
    Fredriksen BN; Grip J
    Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
    Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Particulate Delivery System Based on Antigen-Zn
    Li S; Yang Y; Lin X; Li Z; Ma G; Su Z; Zhang S
    Mol Pharm; 2020 Aug; 17(8):2952-2963. PubMed ID: 32539415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier.
    Zhao Q; Zhang Q; Yue Y; Huang J; Di D; Gao Y; Shao X; Wang S
    Int J Pharm; 2015 Jun; 487(1-2):234-41. PubMed ID: 25895720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
    J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
    Sabel MS; Su G; Griffith KA; Chang AE
    Breast Cancer Res Treat; 2010 Jul; 122(2):325-36. PubMed ID: 19802695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A study on cytocompatibility of poly (lactic acid) membrane modified by polymer microspheres with different surface charges].
    Chen D; Ji J; Shen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Oct; 22(5):966-70. PubMed ID: 16294732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
    Jain AK; Goyal AK; Mishra N; Vaidya B; Mangal S; Vyas SP
    Int J Pharm; 2010 Mar; 387(1-2):253-62. PubMed ID: 20005936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Humoral and cellular immune responses to HBV in the blood donors].
    Yang YL; Huang ZH; Cai XB; Cai J; Ma GM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):404-6. PubMed ID: 22482413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(epsilon-caprolactone) microspheres.
    Chandy T; Wilson RF; Rao GH; Das GS
    J Biomater Appl; 2002 Apr; 16(4):275-91. PubMed ID: 12099508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization.
    Malik B; Goyal AK; Markandeywar TS; Rath G; Zakir F; Vyas SP
    J Drug Target; 2012 Jan; 20(1):76-84. PubMed ID: 21942475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres.
    Ma J; Samuel J; Kwon GS; Noujaim AA; Madiyalakan R
    Cancer Immunol Immunother; 1998 Sep; 47(1):13-20. PubMed ID: 9755874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.